The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The Genio system is now available in the US for OSA patients who meet eligibility criteria. The Food and Drug Administration (FDA) has approved the Genio ® system for the treatment of patients with ...

Nyxoah (NASDAQ:NYXH) used its investor day presentation to outline early U.S. launch progress for its Genio hypoglossal nerve stimulation system, address reimbursement questions and describe its path ...

NyxoahtoReleaseSecond Quarter 2026 Financial Results on August 5, 2026Mont-Saint-Guibert, Belgium – July 27, 2026, 10:05pm CET / 4:05pm ET – ...

(RTTNews) - Nyxoah S.A. (NYXH) has announced the commercial launch of its Genio system in the Middle East, with the first successful implant performed at Saudi German Hospital in Dubai, UAE. Genio is ...

(RTTNews) - Nyxoah SA (NYXH), a medical technology company specializing in innovative treatments for Obstructive Sleep Apnea (OSA), announced the successful implantation of its Genio system in the ...

Mont-Saint-Guibert, Belgium – August 8, 2025, 11:30pm CET / 5:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the“Company”), a medical technology company that develops breakthrough ...

Nyxoah announces data demonstrating the benefits and safety of its Genio system implantation technique for the treatment of Obstructive Sleep Apnea published in Laryngoscope Investigative ...

Mont-Saint-Guibert, Belgium - April 8, 2025, 07:00am CET / 1:00am ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah” or the "Company”), which develops breakthrough treatment alternatives for ...

INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep ApneaU.S. Commercialization Officially Launched Mont-Saint-Guibert ...